Rios, A. M., Chen, C. W., Jacotot, E. D., & Troy, C. M. (2023). Caspase‐2 Inhibition for Treatment of Alzheimer’s Disease. Alzheimer’s & Dementia, 19(S21). Portico. https://doi.org/10.1002/alz.077194

LaRose, M., Connolly, R. M., O’Sullivan, C. C., Velcheti, V., Vilimas, R., Gano, K., Bates, S. E., Pommier, Y., & Thomas, A. (2023). A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid Tumors. The Oncologist, 28(5), 460-e298. https://doi.org/10.1093/oncolo/oyad023

Çoku, J., Booth, D. M., Skoda, J., Pedrotty, M. C., Vogel, J., Liu, K., Vu, A., Carpenter, E. L., Ye, J. C., Chen, M. A., Dunbar, P., Scadden, E., Yun, T. D., Nakamaru‐Ogiso, E., Area‐Gomez, E., Li, Y., Goldsmith, K. C., Reynolds, C. P., Hajnoczky, G., & Hogarty, M. D. (2022). Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance. The EMBO Journal, 41(8). Portico. https://doi.org/10.15252/embj.2021108272